Literature DB >> 33375753

Kinetics of Serological Response in Patients with Severe Fever with Thrombocytopenia Syndrome.

Sang Hyun Ra1, Min Jae Kim1, Min-Chul Kim2, Se Yoon Park3, Seong Yeon Park4, Yong Pil Chong1, Sang-Oh Lee1, Sang-Ho Choi1, Yang Soo Kim1, Keun Hwa Lee5, Sung-Han Kim1, Sun-Ho Kee6.   

Abstract

Severe fever with thrombocytopenia syndrome (SFTS) is caused by SFTS virus (SFTSV). We investigated the detailed kinetics of serologic response in patients with SFTS. Twenty-eight patients aged ≥18 years were enrolled between July 2015 and October 2018. SFTS was confirmed by detecting SFTSV RNA in their plasma using reverse transcription polymerase chain reaction. SFTSV-specific IgG and IgM were measured using immunofluorescence assay (IFA) and enzyme-linked immunosorbent assay (ELISA). We found that SFTSV-specific IgG was detected at days 5-9 after symptom onset, and its titer was rising during the course of disease. SFTSV-specific IgM titer peaked at around week 2-3 from symptom onset. The SFTSV-specific seropositive rates for days 5-9, 10-14, 15-19, and 20-24 from symptom onset using IFA and ELISA were 63%, 76%, 90%, and 100%, and 58%, 86%, 100%, and 100%, respectively, for IgG, whereas they were 32%, 62%, 80%, and 100%, and 53%, 62%, 70%, and 100%, respectively, for IgM. The delayed IgM response could be attributed to the low sensitivity of SFTSV-specific IgM IFA or ELISA and/or impaired immune responses. The IgM test using IFA or ELISA that we used in this study is, therefore, insufficient for the early diagnosis of SFTS.

Entities:  

Keywords:  enzyme-linked immunosorbent assay (ELISA); immunofluorescence assay (IFA); immunoglobulin G (IgG); immunoglobulin M (IgM); severe fever with thrombocytopenia syndrome (SFTS); viral load

Year:  2020        PMID: 33375753     DOI: 10.3390/v13010006

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


  2 in total

1.  Kinetics of Glycoprotein-Specific Antibody Response in Patients with Severe Fever with Thrombocytopenia Syndrome.

Authors:  Hyemin Chung; Eunsil Kim; Bomin Kwon; Yeong-Geon Cho; Seongman Bae; Jiwon Jung; Min-Jae Kim; Yong-Pil Chong; Sung-Han Kim; Sang-Oh Lee; Sang-Ho Choi; Yang-Soo Kim
Journal:  Viruses       Date:  2022-01-27       Impact factor: 5.048

Review 2.  Clinical Update of Severe Fever with Thrombocytopenia Syndrome.

Authors:  Jun-Won Seo; Dayoung Kim; Nara Yun; Dong-Min Kim
Journal:  Viruses       Date:  2021-06-23       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.